Open AccessPattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study
Author(s) -
Jeffrey I. Zwicker,
Adam Rojan,
Federico Campigotto,
Nadia Rehman,
Renee Funches,
Gregory C. Connolly,
Jonathan Webster,
Anita Aggarwal,
Dalia Mobarek,
Charles Faselis,
Doneuberg,
Frederick R. Rickles,
Ted Wun,
Michael B. Streiff,
Alok A. Khorana
Publication year - 2014
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2013.53.5336
Subject(s) - medicine , cancer , medical prescription , odds ratio , prospective cohort study , cross sectional study , anticoagulant , pharmacology , pathology
Hospitalized patients with cancer are considered to be at high risk for venous thromboembolism (VTE). Despite strong recommendations in numerous clinical practice guidelines, retrospective studies have shown that pharmacologic thromboprophylaxis is underutilized in hospitalized patients with cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom